Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Posts $590m Negative EBITDA Amid Opioid Deal And Write-Offs
Russian Invasion Of Ukraine Causes Massive Goodwill Impairment
Jul 28 2022
•
By
Dean Rudge
Teva is looking to return to growth • Source: Christian Horz / Alamy Stock Photo
More from Earnings
More from Business